These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 32418080)
1. ASO Author Reflections: Predictors of Fiscal Outcomes in CRS-HIPEC and Opportunities for Improvement. Schwartz PB; Abbott DE Ann Surg Oncol; 2020 Dec; 27(13):4929-4930. PubMed ID: 32418080 [No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Is CRS/HIPEC an Indication to Divert Rectal Anastomosis? Baron E; Gushchin V; King MC; Sardi A Ann Surg Oncol; 2020 Dec; 27(13):4941-4942. PubMed ID: 32462527 [No Abstract] [Full Text] [Related]
3. ASO Author Reflections: Opportunities for Improving HIPEC Outcomes. Peng JS; Francescutti VA Ann Surg Oncol; 2022 Jan; 29(1):174. PubMed ID: 34581920 [No Abstract] [Full Text] [Related]
4. ASO Author Reflections: Enhanced Recovery After CRS/HIPEC-An Opportunity to Meet Quality Standards. Dahdaleh FS; White B; Salti GI Ann Surg Oncol; 2021 Sep; 28(9):5273-5274. PubMed ID: 33417118 [No Abstract] [Full Text] [Related]
5. ASO Author Reflections: What to Expect After You Resect Diaphragm During CRS/HIPEC. Nikiforchin A; Sittig M; Gushchin V; Sardi A Ann Surg Oncol; 2022 Feb; 29(2):883-884. PubMed ID: 34537898 [No Abstract] [Full Text] [Related]
8. ASO Author Reflections: Should I Stay or Should I Go? Nephrectomy for Complete CRS/HIPEC. Nikiforchin A; Sardi A; King MC; Gushchin V Ann Surg Oncol; 2023 Apr; 30(4):2529-2530. PubMed ID: 36525210 [No Abstract] [Full Text] [Related]
9. ASO Author Reflections: The Potential of ERAS in Standardizing Care for Patients Undergoing CRS-HIPEC. Sun BJ; Lee B Ann Surg Oncol; 2023 Dec; 30(13):8170-8171. PubMed ID: 37707666 [No Abstract] [Full Text] [Related]
10. ASO Author Reflections: Financial Toxicity and CRS-HIPEC-Is a Pound of Debt Worth an Ounce of Cure? Ciftci Y; Radomski SN; Johnston FM; Greer JB Ann Surg Oncol; 2024 Apr; 31(4):2401-2402. PubMed ID: 38087135 [No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Palliative Management of Peritoneal Metastasis Exploring the Risks and Benefits of CRS/HIPEC, a Distinctly Different Context Than Early CRS/HIPEC Intervention With 'Curative Intent'. Foster JM; Zhang C Ann Surg Oncol; 2022 May; 29(5):3347-3348. PubMed ID: 35217972 [No Abstract] [Full Text] [Related]
12. ASO Author Reflections: If Once Is Good, Is Twice Just as Good? A critical evaluation of Repeat CRS-HIPEC for Colorectal Peritoneal Metastases. Laks S; Adileh M; Ben-Yaacov A; Nissan A Ann Surg Oncol; 2021 Sep; 28(9):5339-5340. PubMed ID: 33604829 [No Abstract] [Full Text] [Related]
13. ASO Author Reflections: An Opportunity to Provide Cost-Conscious Care for Patients Undergoing CRS-HIPEC. Schwartz PB; Abbott DE Ann Surg Oncol; 2022 Oct; 29(11):6615-6616. PubMed ID: 35699815 [TBL] [Abstract][Full Text] [Related]
14. ASO Author Reflections: AJCC 8th Edition Performs Well in Predicting Outcomes Among Patients with Disseminated Appendiceal Cancer Undergoing CRS/HIPEC. SenthilKumar G; Cloyd JM; Mogal H Ann Surg Oncol; 2023 Sep; 30(9):5754-5755. PubMed ID: 37322281 [No Abstract] [Full Text] [Related]
15. ASO Author Reflections: To Redo or Not to Redo, That is the Question: Assessing the Slings and Arrows of Repeat CRS/HIPEC in Patients with Recurrent or Progressive Peritoneal Carcinomatosis. Powers BD; Dineen SP Ann Surg Oncol; 2020 Dec; 27(13):4892-4893. PubMed ID: 32318947 [No Abstract] [Full Text] [Related]
16. ASO Author Reflections: Gastric Cancer with Synchronous Peritoneal Disease-A Clinically Meaningful Survival After CRS and HIPEC in Selected Patients from Italian Peritoneal Surface Malignancies Oncoteam Network. Marano L; Marrelli D; Roviello F Ann Surg Oncol; 2021 Dec; 28(13):9071-9072. PubMed ID: 34018086 [No Abstract] [Full Text] [Related]
17. ASO Author Reflections: Standardizing HIPEC Methodology and Regimens: a Prelude to the PSOGI Expert Consensus. Bhatt A; Van Der Speeten K; Hubner M; Kusamura S; Glehen O Ann Surg Oncol; 2021 Dec; 28(13):9114-9115. PubMed ID: 34089108 [No Abstract] [Full Text] [Related]
18. ASO Author Reflections: Characterizing the Peritoneal Immune Response to the Surgical and Thermal Trauma of Peritoneal Cytoreduction and HIPEC. Franko J; Ferrel B; Gorvet M Ann Surg Oncol; 2020 Dec; 27(13):5014-5015. PubMed ID: 32720041 [No Abstract] [Full Text] [Related]
19. ASO Author Reflections: Thirty Years of Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at Wake Forest University. Valenzuela CD; Levine EA; Votanopoulos KI; Shen P Ann Surg Oncol; 2022 Jun; 29(6):3446-3447. PubMed ID: 35275327 [No Abstract] [Full Text] [Related]
20. ASO Author Reflections: International Standardization of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Protocols-Malignant Peritoneal Mesothelioma as a Model. Kepenekian V; Sgarbura O; Marchal F; Villeneuve L; Kusamura S; Deraco M Ann Surg Oncol; 2023 Nov; 30(12):7858-7859. PubMed ID: 37626249 [No Abstract] [Full Text] [Related] [Next] [New Search]